Abstract
Results Mean age was 62 ± 12 years, and 24% were female. 19 patients had a history of previous coronary artery bypass grafting. A stress perfusion defect in viable myocardium was identified in 71 patients (71%). Of these, 52 (73%) subsequently underwent revascularization by either PCI (n = 49) or CABG (n = 3). Revascularisation was either unsuccessful or not performed in 19 patients (27%) due to the absence of significant symptoms, presence of mild perfusion abnormality or poor revascularisation targets. Among the 29 patients in whom no inducible perfusion defects were identified, revascularization was performed in 3 patients (1%) either due to ongoing symptoms (n = 2) or presence of significant luminal area reduction on intravascular ultrasound (IVUS) (n = 1). Follow-up data was available in 93 patients (93%). During a mean follow-up of 10.2 months, no adverse events were observed in patients without inducible perfusion defects on stress perfusion CMR. Among those patients with inducible perfusion defects on CMR who were treated initially with PCI, one patient died during follow-up and four patients were referred for surgical revascularisation due to significant disease progression/restenosis post PCI.
Highlights
Stress perfusion Cardiac MR is increasingly used in patients with established coronary artery disease (CAD) to guide further management
We retrospectively studied 100 consecutive patients with established CAD who underwent adenosine CMR perfusion imaging performed after a median duration of 4 months (IQR: 2.3 - 7months) after their most recent coronary procedure
We examined their hospital electronic records to determine how stress CMR imaging influenced clinical management and outcome
Summary
Vijay Dhakshinamurthy*, Foord Rachel, Redha Boubertakh, Roshan Weerackcody, Joyce Wong, Ceri Davies, Mark Westwood, Steffen Petersen, Anthony Mathur, Mohiddin Saidi, Neha Sekhri. From 2011 SCMR/Euro CMR Joint Scientific Sessions Nice, France. From 2011 SCMR/Euro CMR Joint Scientific Sessions Nice, France. 3-6 February 2011
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.